Cargando…

Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β

Detalles Bibliográficos
Autores principales:	Vinh, Donald C., Abel, Laurent, Bastard, Paul, Cheng, Matthew P., Condino-Neto, Antonio, Gregersen, Peter K., Haerynck, Filomeen, Cicalese, Maria-Pia, Hagin, David, Soler-Palacín, Pere, Planas, Anna M., Pujol, Aurora, Notarangelo, Luigi D., Zhang, Qian, Su, Helen C., Casanova, Jean-Laurent, Meyts, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186356/ https://www.ncbi.nlm.nih.gov/pubmed/34101091 http://dx.doi.org/10.1007/s10875-021-01068-6

Ejemplares similares

Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality
por: Troya, Jesús, et al.
Publicado: (2022)

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
por: Troya, Jesús, et al.
Publicado: (2021)

Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis
por: Chen, Jie, et al.
Publicado: (2021)

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
por: Zhang, Qian, et al.
Publicado: (2022)

Autoantibodies against type I IFNs in patients with critical influenza pneumonia
por: Zhang, Qian, et al.
Publicado: (2022)

IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts
por: Rottman, Martin, et al.
Publicado: (2008)

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
por: Philippot, Quentin, et al.
Publicado: (2023)

The role of IL-12, IL-23 and IFN-γ in immunity to viruses
por: Novelli, Francesco, et al.
Publicado: (2004)

Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
por: Bastard, Paul, et al.
Publicado: (2021)

IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2
por: Lévy, Romain, et al.
Publicado: (2021)

Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
por: Andreakos, Evangelos, et al.
Publicado: (2021)

A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
por: Andreakos, Evangelos, et al.
Publicado: (2021)

Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2
por: Lévy, Romain, et al.
Publicado: (2021)

Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021)

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
por: Manry, Jeremy, et al.
Publicado: (2022)

Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022)

Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease
por: Medina, Gisselle N., et al.
Publicado: (2020)

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
por: Zhang, Qian, et al.
Publicado: (2020)

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
por: Matuozzo, Daniela, et al.
Publicado: (2023)

Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
por: Casanova, Jean-Laurent, et al.
Publicado: (2023)

Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
por: Lopez, Jonathan, et al.
Publicado: (2021)

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
por: Manry, Jérémy, et al.
Publicado: (2022)

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
por: Bastard, Paul, et al.
Publicado: (2020)

IFNα and IFNγ Impede Marek’s Disease Progression
por: Bertzbach, Luca D., et al.
Publicado: (2019)

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
por: Sokal, Aurélien, et al.
Publicado: (2022)

TIM3(+) TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16(+) NK cells delineate MIS-C
por: Hoste, Levi, et al.
Publicado: (2021)

Differential regulation of IFNα, IFNβ and IFNε gene expression in human cervical epithelial cells
por: Couret, Jennifer, et al.
Publicado: (2017)

An eQTL variant of ZXDC is associated with IFN-γ production following Mycobacterium tuberculosis antigen-specific stimulation
por: Jabot-Hanin, Fabienne, et al.
Publicado: (2017)

Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria
por: Philippot, Quentin, et al.
Publicado: (2023)

Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
por: Bastard, Paul, et al.
Publicado: (2021)

Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
por: Zanoni, Ivan, et al.
Publicado: (2017)

Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease
por: Fox, Lindsey E., et al.
Publicado: (2020)

Type I IFN immunoprofiling in COVID-19 patients
por: Trouillet-Assant, Sophie, et al.
Publicado: (2020)

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
por: Duong, Francois H.T., et al.
Publicado: (2014)

IFN gamma regulates proliferation and neuronal differentiation by STAT1 in adult SVZ niche
por: Pereira, Leticia, et al.
Publicado: (2015)

Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γ
por: Rayamajhi, Manira, et al.
Publicado: (2010)

An essential role for IFN-β in the induction of IFN-stimulated gene expression by LPS in macrophages
por: Sheikh, Faruk, et al.
Publicado: (2014)

IFN Signaling: How a Non-Canonical Model Led to the Development of IFN Mimetics
por: Johnson, Howard M., et al.
Publicado: (2013)

A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus
por: Chen, Can, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ipg7esj6jbbj7memq97o7k8j9o